Cefuroxime Injectable Syringes Recalled for Lack of Sterility Assurance
Pine Pharmaceuticals is recalling 4,972 syringes of Cefuroxime injectable medication due to lack of assurance of sterility. The compounded antibiotic was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall of a sterile compounded injectable medication with lack of sterility assurance meets the rubric criterion for Score 3: a risk-of-harm product where injury has not yet been reported. No illnesses or deaths are documented in the source material.
Plain-English summary
Pine Pharmaceuticals, LLC is recalling Cefuroxime 4mg/0.4 mL injectable syringes due to lack of assurance of sterility. The compounded antibiotic was manufactured by Pine Pharmaceuticals in Tonawanda, New York, and may not meet established sterilization standards.
The recall affects approximately 4,972 syringes that were distributed nationwide. The affected product is prescribed by healthcare providers for injectable antibiotic treatment.
Healthcare facilities and patients who have received this medication should stop using it immediately and contact their healthcare provider or supplier. Those with questions about the recall should contact Pine Pharmaceuticals at 355 Riverwalk Parkway, Tonawanda, NY 14150.
Affected lot numbers include: 67918 (Exp. 10/29/2023), 68033 (Exp. 11/4/2023), 68515 (Exp. 11/26/2023), 68528 (Exp. 11/27/2023), 68618 (Exp. 12/2/2023), 68651 (Exp. 12/3/2023), 68767 (Exp. 12/9/2023), 68829 (Exp. 12/11/2023), 69820 (Exp. 1/9/2024), 70733 (Exp. 2/19/2024), 71068 (Exp. 3/9/2024), 67345 (Exp. 10/3/2023).
The recalled product
- Product
- Cefuroxime 4mg /0.4 mL (10 mg/mL), 1mL syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
- Manufacturer
- Pine Pharmaceuticals, LLC
- Affected units
- 4,972
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 67918
- Exp. Date 10/29/2023
- 68033
- Exp. Date 11/4/2023
- 68515
- Exp. Date 11/26/2023
- 68528
- Exp. Date 11/27/2023
- 68618
- Exp. Date 12/2/2023
- 68651
- Exp. Date 12/3/2023
- 68767
- Exp. Date 12/9/2023
- 68829
- Exp. Date 12/11/2023
- 69820
- Exp. Date 1/9/2024
- 70733
- Exp. Date 2/19/2024
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Pine Pharmaceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Pine Pharmaceuticals, LLC
See all →- HighFDA Recalls Compounded Moxifloxacin Syringes for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighFoscarnet Sodium Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighTPC Drops Ophthalmic Solution Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighCompounded Intranasal Lidocaine-Oxymetazoline Solution Recalled Due to Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighLidocaine eye drops recalled due to lack of sterility assurance
FDA (Drugs) · 2023-10-25
Same hazard · contamination
See all →- HighMedline Convenience Kits Recalled Due to Potential Packaging Seal Defects
FDA (Devices) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to Contamination
FDA (Drugs) · 2026-09-09
- HighMedline Convenience Kits Recalled Due to Potential Applicator Seal Defects
FDA (Devices) · 2026-09-09
- HighMedline Ortho Aspiration Kits Recalled for Potential Contamination
FDA (Devices) · 2026-09-09